YEDA RESEARCH AND DEVELOPMENT CO. LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 24867
 
  
 
C07K PEPTIDES 13034
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12358
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 59147
 
  
 
C07D HETEROCYCLIC COMPOUNDS 36126
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3491
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3267
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 3164
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 27420
 
  
 
H01L SEMICONDUCTOR DEVICES; ELECTRIC SOLID STATE DEVICES NOT OTHERWISE PROVIDED FOR 24338

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,369 GLUTAMATE OXALOACETATE TRANSAMINASE 1 (GOT1), PREPARATIONS AND METHODS OF GENERATING SAME AND USES THEREOFMar 31, 16Mar 15, 18[A61K, C12N]
2018/0064,639 LOW FREQUENCY GLATIRAMER ACETATE THERAPYNov 13, 17Mar 08, 18[A61K]
2018/0064,682 INHIBITORS OF LEUKOTRIENE-MEDIATED ACTIVITY FOR TREATING SIDE EFFECTS OF STATIN THERAPYOct 31, 17Mar 08, 18[A61K]
2018/0064,748 METHODS OF TREATING MOTOR NEURON DISEASESMar 27, 16Mar 08, 18[A61K, C12N]
2018/0066,286 NUCLEAR TARGETING SEQUENCESNov 01, 17Mar 08, 18[A61K, C12N, C07K]
2018/0042,994 METHODS OF TREATING DISEASES RELATED TO MITOCHONDRIAL FUNCTIONNov 17, 15Feb 15, 18[A61K, C12N]
2018/0028,650 METHODS OF PREVENTING SECONDARY INFECTIONSFeb 09, 16Feb 01, 18[A61K, C07K]
2018/0009,893 Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNSSep 08, 17Jan 11, 18[A61K, C07K]
2017/0362,296 PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASESSep 06, 17Dec 21, 17[A61K, C07K]
2017/0348,393 TREATMENT OF CNS INFLAMMATORY DISORDERSNov 05, 15Dec 07, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9909135 Transgenic plants having altered DAHP synthase activityJul 06, 11Mar 06, 18[C12N, A01H]
9901299 Activating functional electrical stimulation of abdominal muscles to assist coughingDec 09, 14Feb 27, 18[A61B, G06F, A61N]
9901593 Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditionsSep 17, 15Feb 27, 18[A61K, C12Q, C12N]
9901660 Low friction hydrogels and hydrogel-containing composite materialsJul 03, 14Feb 27, 18[A61K, C08F, C09D, A61L]
9902783 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteinsMay 23, 16Feb 27, 18[C07F, C07D, C07K]
9890202 Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseasesJul 19, 11Feb 13, 18[A61K, C07K]
9877806 Low friction coatings for use in dental and medical devicesMay 17, 06Jan 30, 18[C23C, C25D, C10M, F16C, A61C, A61L]
9873612 ) from biomassOct 28, 14Jan 23, 18[C01B, C25B, C10K, C07C, B01J, C10G]
9867576 Computer-accessible medium, system and method for assessing effect of a stimulus using intersubject correlationNov 09, 15Jan 16, 18[A61B]
9856289 Peptides capable of reactivating p53 mutantsFeb 04, 16Jan 02, 18[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0294,572 SPIN TRANSPORT ELECTRONIC DEVICEAbandonedMar 25, 15Oct 12, 17[H01L, G11C]
2017/0172,979 INHIBITORS OF LEUKOTRIENE-MEDIATED ACTIVITY FOR TREATING SIDE EFFECTS OF STATIN THERAPYAbandonedFeb 18, 15Jun 22, 17[A61K]
2017/0165,285 METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORSAbandonedFeb 22, 17Jun 15, 17[A61K, C07K]
2017/0119,847 SHORT BETA-DEFENSIN-DERIVED PEPTIDESAbandonedDec 28, 16May 04, 17[A61K]
2017/0009,211 DOWNREGULATION OF miR-7 FOR PROMOTION OF BETA CELL DIFFERENTIATION AND INSULIN PRODUCTIONAbandonedSep 28, 16Jan 12, 17[C12N, C07K]
2016/0319,287 ATYPICAL INTEINSAbandonedDec 12, 14Nov 03, 16[C12N, C07K]
2016/0243,547 MICROFLUIDIC DEVICE FOR ANALYZING GENE EXPRESSIONAbandonedOct 07, 14Aug 25, 16[C12P, B01L, B01J]
2016/0213,762 METHOD AND VACCINE COMPRISING COPOLYMER 1 FOR TREATMENT OF PSYCHIATRIC DISORDERSAbandonedApr 11, 16Jul 28, 16[A61K]
2016/0184,426 Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune ResponseAbandonedApr 10, 14Jun 30, 16[A61K, C07K]
2016/0166,582 PROTEASOME INHIBITORS AND USES THEREOFAbandonedFeb 23, 16Jun 16, 16[A61K, G01N, C07K]
2016/0133,925 FULLERENE-LIKE NANOPARTICLES AND INORGANIC NANOTUBES AS HOST ELECTRODE MATERIALS FOR SODIUM/MAGNESIUM ION BATTERIESAbandonedDec 17, 15May 12, 16[H02J, H01M]
2016/0122,758 AGENTS FOR DOWNREGULATION OF THE ACTIVITY AND/OR AMOUNT OF BCL-XL AND/OR BCL-WAbandonedApr 13, 14May 05, 16[A61K, C12N]
2016/0122,765 QSOX1 AS AN ANTI-NEOPLASTIC DRUG TARGETAbandonedSep 09, 15May 05, 16[C12N]
2016/0103,192 SENSOR DEVICE FOR DIRECT MAGNETIC FIELD IMAGINGAbandonedMay 20, 14Apr 14, 16[G01R]
2016/0069,896 DIAGNOSIS OF AUTOIMMUNE DISEASES USING A SPECIFIC ANTIBODY PROFILEAbandonedDec 16, 13Mar 10, 16[G01N]
2016/0002,269 LANTHANIDE CLUSTERS AND METHODS OF USE THEREOFAbandonedFeb 13, 14Jan 07, 16[C09K, A61K, C07F, C09D, G01N]
2015/0366,944 INTERFERON TREATMENT TARGETING MUTANT P53 EXPRESSING CELLSAbandonedFeb 19, 14Dec 24, 15[A61K, C12Q, G01N, C07K]
2015/0362,737 WIDE FIELD IMAGING USING PHYSICALLY SMALL DETECTORSAbandonedJan 28, 14Dec 17, 15[H04N, G06T, G02B]
2015/0356,704 GOOD PLANAR MAPPINGS AND CONTROLLING SINGULAR VALUES WITH SEMIDEFINITE PROGRAMMINGAbandonedJun 08, 15Dec 10, 15[G06T, G06F]
2015/0297,693 PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSESAbandonedJun 30, 15Oct 22, 15[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.